Categories | Unadjusted | Multivariate | ||||
OR | CI | P-Value | OR | CI | P-Value | |
Age in years | 0.964 | 0.932 - 0.997 | 0.0336** | 0.964 | 0.932 - 0.997 | 0.0336** |
Disease Duration (in years) | 1.018 | 0.967 - 1.073 | 0.4963 |
|
|
|
Diagnosis Duration (in years) | 1.017 | 0.967 - 1.070 | 0.5037 |
|
|
|
Gender | 1.239 | 0.587 - 2.617 | 0.5740 |
|
|
|
Race | 0.689 | 0.202 - 2.351 | 0.5514 |
|
|
|
Education |
| |||||
College | 1.636 | 0.603 - 4.444 | 0.3340 |
|
|
|
Graduate | 0.865 | 0.256 - 2.922 | 0.8159 |
|
|
|
Medication Groups |
| |||||
Carbidopa-Levodopa | 1.123 | 0.495 - 2.548 | 0.7809 |
|
|
|
COMT Inhibitors | 1.265 | 0.495 - 3.232 | 0.6229 |
|
|
|
Dopamine Agonists | 0.800 | 0.353 - 1.813 | 0.5929 |
|
|
|
MAO Inhibitors | 1.309 | 0.512 - 3.347 | 0.5736 |
|
|
|
Total Number of Medications | 1.038 | 0.814 - 1.324 | 0.7648 |
|
|
|
Total Number of Medication Groups | 1.042 | 0.747 - 1.453 | 0.8082 |
|
|
|